AKAtsuko Kitano

Atsuko Kitano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Atsuko Kitano has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Music therapy preferences among breast cancer patients undergoing perioperative chemotherapy: from qualitative insight to quantitative evidence

    by Nanami Nakaya, Ami Yamasato, Mayu Kondo, Shigeki Okino, Atsuko Kitano, Banri Tsuda, Makoto Tokuhara, Kenji Yamamoto

    Background: Patients with breast cancer (PWBC) have a high risk of developing psychological disorders, and interventions should be implemented with care. For music therapy (MT) interventions to be more effective among these patients, providing therapeutic programs tailored to their preferences is desirable. Given the limited research on the preferences for MT of PWBC undergoing chemotherapy, we had previously conducted a qualitative study to clarify their preferences, yielding the formation of related hypotheses. Building upon these hypotheses, the current quantitative study aimed to clarify the specific preferences regarding MT of PWBC, who are undergoing chemotherapy, in Japan. Methods: This quantitative study’s questionnaire was created based on the results of our prior qualitative study and completed by 300 PWBC undergoing perioperative chemotherapy. Results: (a) Of all participants, 80.9% wanted MT, and there was a relationship between preferred activity type and participants’ sociodemographic and clinical characteristics; (b) the expectations of participants regarding MT differed by preferred activity type; and (c) the participants’ preferences regarding the frequency, timing, duration, and cost of the MT intervention were constant regardless of the preferred activity type. Conclusions: As patients’ specific preferences have been clarified, we conclude that professionals may be more well-positioned and informed to devise more appropriate and effective MT programs to be incorporated into the treatment schedules of PWBC who are undergoing chemotherapy, with vital quality-of-life implications resulting.


  • Music Therapy Preferences Among Breast Cancer Patients Undergoing Chemotherapy: A Qualitative Study

    by Nanami Nakaya, Ami Yamasato, Mayu Kondo, Shigeki Okino, Atsuko Kitano, Kenji Yamamoto

    Evidence suggests that music therapy may be effective for patients with cancer. However, its efficacy can be improved by tailoring it to each patient’s needs, disease, and treatment conditions. Since few studies have investigated the music therapy preferences of patients with cancer, this qualitative study aimed to identify such preferences among patients with breast cancer undergoing chemotherapy. For this purpose, individual semi-structured interviews were conducted with 14 adult patients with breast cancer who had received perioperative chemotherapy in Japan. The data were analyzed based on a grounded theory approach, revealing the following categories: (a) relationship to music, (b) pain from treatment, and (c) preferences for music therapy. Based on these results, we were able to determine the specific music therapy preferences of patients with breast cancer undergoing chemotherapy. In addition, we identify patient preferences for music therapy content, time, timing, and fees and discuss the process of meeting these preferences. Identifying these preferences is crucial to providing meaningful interventions to music therapy recipients.


  • Open Access

    Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.


  • Open Access

    Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.

    Background: Financial toxicity (FT) is a notable concern for patients with breast cancer worldwide. The situation regarding FT in Japan, however, has not been well explored. This study examined FT in patients with breast cancer in Japan and presented an overview of the group study’s overall findings. Methods: The survey used the Questant application and primarily targeted patients with breast cancer attending research facilities and physicians who are members of the Japanese Breast Cancer Society. The Japanese version of the Comprehensive Score for FT (COST) was used to quantify patients’ FT. Multiple regression analysis was used to identify factors related to FT in patients with breast cancer in Japan and evaluate the sufficiency of information support level (ISL) for medical expenses. Results: We collected 1558 responses from patients and 825 from physicians. In terms of factors affecting FT, recent payments had the highest impact, followed by stage, and related departments positively affecting FT. Conversely, factors such as income, age, and family support were found to negatively affect FT. A significant discrepancy was identified between patients and physicians in perceived information support, with patients frequently feeling unsupported and physicians believing that they have provided adequate support. Furthermore, differences in the frequency of explanations and opportunities to ask questions about medical costs across FT grades were found. The analysis also showed that physicians with a better understanding of information support needs and greater knowledge of medical costs tended to provide more support that is comprehensive. Conclusion: This study emphasizes the importance of addressing FT in patients with breast cancer in Japan and highlights the need for enhanced information support, deeper understanding by physicians, and collaborative efforts among professionals to mitigate financial burden and provide personalized, tailored support for individual needs.


  • Open Access

    Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician Perspectives

    by Sumito Saeki, Tsuguo Iwatani, Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, Yusuke Kajimoto, Sayaka Kuba, Fumikata Hara, et al.

    Background Patients with breast cancer are generally younger than those with other types of cancer. Their treatment often lasts for longer period, leading to increased costs and indirect burdens such as managing adverse events. Financial toxicity (FT) is a significant concern for patients with breast cancer worldwide, and the lack of medical cost information support in the United States is a notable issue. However, the situation regarding FT in Japan has not been well explored. Parallel with other related studies, this study aimed to examine FT in patients with breast cancer in Japan and present an overview of the group study’s overall findings.Methods The survey utilized the Questant application and primarily targeted patients with breast cancer attending research facilities and physicians who are Japanese Breast Cancer Society members. The Japanese version of the Comprehensive Score for FT (COST) was used to quantify patients’ FT. Multiple regression analysis was used to identify factors related to FT in patients with breast cancer in Japan and evaluate the sufficiency of information support level (ISL) for medical expenses.Results We collected 1,558 responses from patients and 825 from physicians. The results showed that recent payment was the most significant factor affecting patients’ FT. Furthermore, inadequate ISL by physicians was found, with ISL tending to decrease as FT increased. Regional differences in patients’ ISL were also identified. Physicians with a better understanding of information support needs and adequate knowledge of medical costs tended to provide more comprehensive support.Conclusion This study emphasizes the importance of addressing FT in patients with breast cancer in Japan and highlights the need for enhanced information support, deeper understanding by physicians, and collaborative efforts among professionals to mitigate financial burden and provide personalized, tailored support for individual needs.

  • Open Access

    Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists

    by Atsuko Kitano, Chikako Shimizu, Hideko Yamauchi, Fumi Akitani, Kyoko Shiota, Yoko Miyoshi, Sachiko Ohde

    Purpose Cancer treatment delay due to fertility preservation procedures is a barrier for patients with breast cancer who wish to preserve their fertility. This study aimed to describe the associations between fertility preservation and treatment delay in patients with breast cancer with reproductive concerns and assess the factors related to treatment delay. Methods Patients with primary breast cancer who visited the reproductive unit at our institution before cancer treatment between 2007 and 2015 were enrolled. The treatment delay cut-off was defined as follows: time to chemotherapy (TTC) >8 weeks for patients intending to receive neoadjuvant chemotherapy, TTC >12 weeks for patients intending to receive adjuvant chemotherapy, time to endocrine therapy (TTE) >12 weeks for patients intending to receive endocrine therapy without radiation therapy and TTE >20 weeks for patients intending to receive endocrine therapy after radiation therapy. Multivariable models were constructed to examine the factors of treatment delay. Results Overall, 212 patients met the inclusion criteria. Using the defined cut-offs, treatment delay was noted in 18% of the patients. Endocrine therapy was related to treatment delay (OR 4.49, 95% CI 1.02 to 19.7; p=0.05), but fertility preservation by artificial reproductive treatment (ART) was not. Pregnancy and delivery following treatment for breast cancer were achieved in 18 (19%) and 15 (16%) patients who underwent fertility preservation with ART. Conclusion Fertility preservation with ART was not associated with treatment delay in patients with breast cancer who were referred to reproductive specialists before cancer treatment.